Medinews

Notizie AIOM – anno XVI

18 Dicembre 2018

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

Gemcitabine plus nanoparticle albumin-bound (NAB) paclitaxel (GA) significantly improved survival compared with gemcitabine alone in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and a Karnofsky performance status (PS) of 70% or greater. Because of the ...
Leggi tutto
17 Dicembre 2018

10 dicembre 2018 – Dose Flat Pembrolizumab (Merck Sharp & Dohme)

17 Dicembre 2018

12 dicembre 2018 – Utilizzo dei biosimilari di trastuzumab in associazione a pertuzumab nel carcinoma mammario Her2 positivo metastatico